Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

Clinical trial NCT00473668 · COMPLETED

Trial details

NCT number: NCT00473668
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Whole Cell Pertussis Haemophilus Influenzae Type b Tetanus Diphtheria Hepatitis B

Start date: 2007-06-01
Primary completion: 2008-01-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.